Key result
Device-detected AHRE linked to ~233% greater risk of clinical AF and thromboembolic events.
Why the study?
Outcomes of device-detected AF remain unclear in individuals without a prior history of AF.
Does device-detected atrial fibrillation increase the risk of clinical AF, thromboembolism, and mortality in individuals with no prior history of AF?
Meta-Analysis (n=7,440)
Does device-detected atrial fibrillation increase the risk of clinical AF, thromboembolism, and mortality in individuals with no prior history of AF?
Answers are grounded in this paper and cite their sources.
Device-detected atrial high-rate episodes in patients without prior AF are associated with a significantly increased risk of subsequent clinical AF and thromboembolism, particularly when episodes last >24 hours.
Background: Outcomes of device-detected AF remain unclear in individuals without a prior history of AF. Methods: A meta-analysis was conducted to evaluate outcomes in individuals with no prior history of AF who experienced device-detected AF. Outcomes assessed were clinical AF, thromboembolism and all-cause mortality. A fixed-effects model was used to calculate RRs with 95% CI. Results: Compared to individuals who did not experience device-detected AF, those who did had increased risks of clinical AF (RR 3.33, 95% CI [1.99.5.57]; p<0.0001) and thromboembolic events (RR 2.21; 95% CI [1.72.2.85]; p<0.0001). The risk of all-cause mortality was similar between both groups (RR 1.19; 95% CI [0.95.1.49]; p=0.13). Subgroup analysis revealed an increased risk of thromboembolic events among device-detected AF .24 hours (RR 12.34; 95% CI [2.70.56.36]). Conclusion: While there is an increased risk of clinical AF and thromboembolism in individuals with device-detected AF, mortality was insignificant.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2024) conducted a meta-analysis in Device-detected Atrial High-rate Episodes (AHREs) without prior history of Atrial Fibrillation (n=7,440). Device-detected Atrial High-rate Episodes (AHREs) vs. No device-detected Atrial High-rate Episodes was evaluated on Clinical Atrial Fibrillation (RR 3.33, 95% CI 1.99-5.57, p=<0.0001). Device-detected atrial high-rate episodes increased the risk of clinical atrial fibrillation and thromboembolic events in patients with no prior history of AF.
Synapse has enriched 10 related papers. Consider them for comparative context: